Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
YorLabs has received FDA 510(k) clearance for its Intracardiac Imaging System, a zero-capex ultrasound platform designed for electrophysiology and interventional cardiology procedures. The system enables single-operator control and offers high-resolution, real-time imaging for cardiac interventions.
ChemDiv has extended its discovery and early development partnership with Mondego Bio to advance a PTPN2-targeting immuno-oncology program, following Mondego's Series A financing led by Biovance Capital.
Northwest Biotherapeutics has finalized its acquisition of Advent BioServices, making it a wholly owned subsidiary. The deal includes all Advent assets and intellectual property, with payments to be made over two years.
MindHYVE.ai and the Prime Institute of Health Sciences have announced a partnership to implement AI platforms across education and healthcare in Pakistan, introducing ArthurAI in classrooms and ChironAI in hospitals.
At the 20th International Conference on Genomics in Hangzhou, BGI-Research and Zhejiang Lab introduced Genos, an open-source genomic foundation model with over 10 billion parameters aimed at advancing personalized medicine and genomic interpretation.
BiomEdit has been awarded nearly $2 million from the Bezos Earth Fund to develop an AI-based model aimed at reducing methane emissions in cattle while improving productivity and welfare. The project, conducted with Bioversity International USA and Yale University, will train a generative AI system using data from over 20,000 ruminants across more than 25 countries.
OpenAI, Founders Fund, and Lux Capital have invested $30 million in biosecurity startup Valthos, which has emerged from stealth to develop AI tools for detecting and countering biological threats.
Spring Health is supporting the formation of the AI in Mental Health Safety & Ethics Council, a cross-sector group developing standards for responsible AI use in mental health care, including an open-source evaluation framework called VERA-MH.
Swiss Rockets AG and Squirro AG have entered a strategic partnership to implement Squirro’s Generative AI Platform as the foundation of Swiss Rockets’ digital knowledge ecosystem, aimed at improving research efficiency and decision-making across its biotech portfolio.
Alife Health has obtained CE Mark certification under the European Medical Device Regulation for its AI-powered embryo selection platform, Embryo Predict, enabling rollout across IVF clinics in the EU.
Adtalem Global Education has partnered with Google Cloud to introduce a new AI credentials program for healthcare professionals, offering hands-on training with Google Cloud's AI technologies including Gemini and Vertex AI. The program, launching in 2026, will be available across Adtalem's network of institutions.
Electra Therapeutics has raised $183 million in a Series C financing co-led by EQT Life Sciences and Nextech, with participation from Sanofi and other investors, to advance its immunology and cancer programs.
DrugBank has named Lisa Downey as its new CEO, with Co-Founder Mike Wilson transitioning to Chief Product Officer to focus on AI and data intelligence initiatives.
Lightbeam Health Solutions announced that its clients in the Medicare Shared Savings Program generated over $444 million in gross savings during 2024, outperforming national averages in both cost reduction and quality scores.
Brook.ai has appointed former Teladoc Health COO Mike Waters as Chairman of the Board as the company expands its commercial operations and partnerships across health systems.
Tri-City Cardiology has broadened its partnership with Basata to integrate AI-powered voice agents into patient communication, further embedding artificial intelligence into its healthcare operations.
Family Health Choice has announced a partnership with MediKarma to integrate MediKarma's Agentic AI platform into its services, offering members personalized wellness tools and proactive care support starting November 1, 2025.
Alethios has launched a software platform designed to make structured, outcomes-based human health research more accessible. The platform includes tools for study design, recruitment, and management, using generative AI to streamline processes that traditionally take months.
Google Research has unveiled DeepSomatic, an AI model designed to identify cancer-related genetic mutations in tumor cells. The tool uses convolutional neural networks to improve accuracy across multiple sequencing technologies and is now openly available to the research community.
Google and Yale University have introduced C2S-Scale 27B, a 27-billion-parameter AI model for detailed single-cell analysis. The system has shown potential in identifying drug interactions that could support cancer immunotherapy.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
